Search research articles
Contact Us
Filters
Showing results (41-50 of 81) with videos related to
Page
of 9
Sort By:
Experimental Neurology
|
August 28, 2023
Quinpirole inhibits levodopa-induced dyskinesias at structural and behavioral levels: Efficacy negated by co-administration of isradipine
Timothy J Collier, Lauren Begg, Jennifer A Stancati, et al.
Muscle & Nerve
|
April 22, 2025
The Impact of Brain-Derived Neurotrophic Factor rs6265 (Val66Met) Polymorphism on Therapeutic Electrical Stimulation for Peripheral Nerve Regeneration: A Preclinical Study of Therapy-Genotype Interactions
Jordan B Walters, Maria J Quezada, Suning He, et al.
NPJ Parkinson'S Disease
|
August 23, 2024
Advancing age and the rs6265 BDNF SNP are permissive to graft-induced dyskinesias in parkinsonian rats
Natosha M Mercado, Carlye Szarowicz, Jennifer A Stancati, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 20, 2019
Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia
Kathy Steece-Collier, Jennifer A Stancati, Nicholas J Collier, et al.
Journal of Neuroscience Methods
|
January 15, 2013
Advances in thin tissue Golgi-Cox impregnation: fast, reliable methods for multi-assay analyses in rodent and non-human primate brain
Nathan D Levine, David J Rademacher, Timothy J Collier, et al.
Neurobiology of Disease
|
January 27, 2007
Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism
Timothy J Collier, Jack Lipton, Brian F Daley, et al.
Brain Research
|
March 21, 2007
Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease
Deanna M Marchionini, Elin Lehrmann, Yaping Chu, et al.
Cell Transplantation
|
April 4, 2015
A potential compensatory role for endogenous striatal tyrosine hydroxylase-positive neurons in a nonhuman primate model of Parkinson's disease
Andrew N Bubak, D Eugene Redmond, John D Elsworth, et al.
Neurobiology of Disease
|
March 31, 2023
Downregulation of striatal Ca<sub>V</sub>1.3 inhibits the escalation of levodopa-induced dyskinesia in male and female parkinsonian rats of advanced age
Margaret E Caulfield, Molly J Vander Werp, Jennifer A Stancati, et al.
Annals of Neurology
|
July 25, 2006
Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys
Jeffrey H Kordower, Nicholas M Kanaan, Yaping Chu, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 81) with videos related to
Sort By:
Page
of 9
Experimental Neurology
|
August 28, 2023
Quinpirole inhibits levodopa-induced dyskinesias at structural and behavioral levels: Efficacy negated by co-administration of isradipine
Timothy J Collier, Lauren Begg, Jennifer A Stancati, et al.
Muscle & Nerve
|
April 22, 2025
The Impact of Brain-Derived Neurotrophic Factor rs6265 (Val66Met) Polymorphism on Therapeutic Electrical Stimulation for Peripheral Nerve Regeneration: A Preclinical Study of Therapy-Genotype Interactions
Jordan B Walters, Maria J Quezada, Suning He, et al.
NPJ Parkinson'S Disease
|
August 23, 2024
Advancing age and the rs6265 BDNF SNP are permissive to graft-induced dyskinesias in parkinsonian rats
Natosha M Mercado, Carlye Szarowicz, Jennifer A Stancati, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 20, 2019
Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia
Kathy Steece-Collier, Jennifer A Stancati, Nicholas J Collier, et al.
Journal of Neuroscience Methods
|
January 15, 2013
Advances in thin tissue Golgi-Cox impregnation: fast, reliable methods for multi-assay analyses in rodent and non-human primate brain
Nathan D Levine, David J Rademacher, Timothy J Collier, et al.
Neurobiology of Disease
|
January 27, 2007
Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism
Timothy J Collier, Jack Lipton, Brian F Daley, et al.
Brain Research
|
March 21, 2007
Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease
Deanna M Marchionini, Elin Lehrmann, Yaping Chu, et al.
Cell Transplantation
|
April 4, 2015
A potential compensatory role for endogenous striatal tyrosine hydroxylase-positive neurons in a nonhuman primate model of Parkinson's disease
Andrew N Bubak, D Eugene Redmond, John D Elsworth, et al.
Neurobiology of Disease
|
March 31, 2023
Downregulation of striatal Ca<sub>V</sub>1.3 inhibits the escalation of levodopa-induced dyskinesia in male and female parkinsonian rats of advanced age
Margaret E Caulfield, Molly J Vander Werp, Jennifer A Stancati, et al.
Annals of Neurology
|
July 25, 2006
Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys
Jeffrey H Kordower, Nicholas M Kanaan, Yaping Chu, et al.
Page
of 9